Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis-Reference-Cited by-同舟云学术

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Published:2016-02-08 Issue:2 Volume:23 Page:71-79
ISSN:0928-6586
Container-title:Ophthalmic Epidemiology
language:en
Short-container-title:Ophthalmic Epidemiology

Author:

Souied Eric H.,Dugel Pravin U.,Ferreira Alberto,Hashmonay Ron,Lu Jingsong,Kelly Simon P.

Funder

Novartis Pharma AG, Basel, Switzerland

Publisher

Informa UK Limited

Subject

Ophthalmology,Epidemiology

Link

https://tandfonline.com/doi/pdf/10.3109/09286586.2015.1090004

Reference58 articles.

1. Age and Gender Variations in Age-related Macular Degeneration Prevalence in Populations of European Ancestry: A Meta-analysis

2. Anti-vascular endothelial growth factor therapy for diabetic macular edema

3. Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review

4. Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Diabetic Macular Edema

5. Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic Review

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and Nonsurgical Trauma;Ocular Pathology;2025

2. Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients;American Journal of Ophthalmology;2025-01

3. A real-world data analysis of ocular adverse events linked to anti-VEGF drugs: a WHO-VigiAccess study;Frontiers in Pharmacology;2024-07-30

4. Acute Noninfectious Anterior Ocular Inflammation Following Ranibizumab Biosimilar Intravitreal Injection in a Patient With Recent COVID-19 Vaccination;Cureus;2024-05-15

5. Intraocular inflammation as a major adverse event of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: from clinical trials to real-world practice;Expert Opinion on Drug Safety;2024-05-06